Latest filing published 16 Sept 2016 for Diplomat Pharmacy, Inc., €55k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Atheer A. Kaddis: trading record in brief
Atheer A. Kaddis appears in our data through filings on Diplomat Pharmacy, Inc. shares, published by SEC (Form 4). The record holds 26 filings, for trades running from 9 October 2014 to 15 September 2016.
Both buying and selling appear: 1 purchase worth €41k, against 14 sales worth €4.8M. Taken together, the sales exceed the purchases by €4.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 11 option exercises. So far in 2016, the count stands at no purchases and 11 sales.
On 16 September 2016 came the latest disclosure, an option exercise for €55k in Diplomat Pharmacy, Inc. The last purchase on record was published on 10 October 2014, which is 4,413 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Atheer A. Kaddis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$3.071.5% of flowCommon StockSEC:0001596771-16-000154:0
- 20,000 shares@ US$30.1214.8% of flowCommon StockSEC:0001596771-16-000154:1
- 12,325 shares@ US$3.070.9% of flowCommon StockSEC:0001596771-16-000138:0
- 9,025 shares@ US$35.648.0% of flowCommon StockSEC:0001596771-16-000138:1
- 3,300 shares@ US$36.112.9% of flowCommon StockSEC:0001596771-16-000138:2
- 12,325 shares@ US$3.070.9% of flowCommon StockSEC:0001596771-16-000122:0
- 12,325 shares@ US$35.0410.7% of flowCommon StockSEC:0001596771-16-000122:1
- 12,325 shares@ US$3.070.9% of flowCommon StockSEC:0001596771-16-000115:0
- 7,800 shares@ US$32.166.2% of flowCommon StockSEC:0001596771-16-000115:1
- 4,525 shares@ US$32.573.6% of flowCommon StockSEC:0001596771-16-000115:2
- 12,325 shares@ US$3.070.9% of flowCommon StockSEC:0001596771-16-000108:0
- 12,325 shares@ US$30.178.9% of flowCommon StockSEC:0001596771-16-000108:1
- 24,650 shares@ US$3.071.9% of flowCommon StockSEC:0001596771-16-000104:0
- 24,650 shares@ US$30.0018.1% of flowCommon StockSEC:0001596771-16-000104:1
- 12,325 sharesCommon StockSEC:0001596771-16-000089:0
- 12,325 shares@ US$30.0046.2% of flowCommon StockSEC:0001596771-16-000089:1
- 12,325 sharesCommon StockSEC:0001596771-16-000082:0
- 9,700 shares@ US$33.426642.2% of flowCommon StockSEC:0001596771-16-000082:1
- 2,625 shares@ US$33.963211.6% of flowCommon StockSEC:0001596771-16-000082:2
- 12,325 shares@ US$3.07Common StockSEC:0001596771-15-000079:0
- 12,325 shares@ US$34.75Common StockSEC:0001596771-15-000079:1
- 24,650 shares@ US$3.07Common StockSEC:0001596771-15-000077:0
- 24,650 shares@ US$30.00Common StockSEC:0001596771-15-000077:1
- 12,325 shares@ US$3.07Common StockSEC:0001619008-15-000001:0
- 12,325 shares@ US$37.42Common StockSEC:0001619008-15-000001:1
25 of 26 declarations